个人介绍 学术任职 学术论着 专家风采
2008年毕业于北京大学获医学博士学位，此后就职于timi天美传孟若羽血液科，长期从事血液肿瘤化疗、免疫治疗及造血干细胞移植临床工作。作为血液病学副教授及中级生物信息工程师，长期从事血液肿瘤基因诊断相关工作，擅长血液肿瘤及遗传性疾病的诊断与治疗，以及遗传性和非遗传性罕见病的造血干细胞移植、移植相关合并症诊治。
担任血液科化疗及移植病房主治医师、查房教授等工作近20年，具有丰富的血液肿瘤诊疗及造血干细胞移植、颁础搁罢等免疫治疗经验，累计完成上千例移植患者的治疗与随访工作。从事血液肿瘤基因诊断相关工作多年，主持我院血液肿瘤相关基因变异咨询多学科会诊(惭顿罢)工作，每年惭顿罢诊疗人次近千例。作为主要研究者及厂滨，承担多项国际前瞻性临床试验分中心研究。科研方面聚焦于血液肿瘤诊断及移植相关合并症方面，主持省部级、院校级课题6项，发表厂颁滨及核心期刊论文20余篇。长期从事住院医及进修医培训等教学工作，指导临床及临床科研方面工作，作为副导师，指导两名博士研究生，2024年聘任为硕士研究生导师。
中华医学会血液学分会第十二届委员会实验诊断学组委员；中国临床肿瘤学会白血病专家委员会委员；中国抗癌协会血液肿瘤专业委员会青年委员；中国妇幼保健协会脐带血应用专业委员会委员。
1.Yang X, Liang Z#, Ji L, Liu W, Wang B, Li Y, Ou J, Cen X, Ren H, Wuchty S, Zhang Z, Dong Y. Comparative outcome and prognostic factor analysis among MDS/AML patients with TP53 mutations, snps, and wild type. Hum Genomics. 2025 Aug 28;19(1):98.
2.Liu Y, Liang Z#, Ren H, Dong Y, Liu W, Yin Y, Wang B, Wang Q, Wang Q, Li Y. Comparative retrospective analysis of cord blood transplantation with ATG-containing conditioning regimens and haploidentical stem cell transplantation: similar survival outcomes with reduced incidence of GVHD. Ann Med. 2025 Dec;57(1):2447402.
3.Wang Q, Liang Z#, Ren H, Dong Y, Yin Y, Wang Q, Liu W, Wang B, Han N, Li Y, Li Y. Real-world outcomes and prognostic factors among patients with acute myeloid leukemia treated with allogeneic hematopoietic stem cell transplantation. Ann Hematol. 2023 Nov;102(11):3061-3074.
4.Ze-Yin L#, Hao Z, Ru-Li F, Yu-Jun D, Xiao-Ping C. A case of Nonomuraea blood infection, Beijing, China. Clin Microbiol Infect. 2023 Oct;29(10):1342-1344.
5.Yu JM, Liang ZY#, Guo K, Sun XM, Zhang Q, Dong YJ, Duan ZJ. Intra-Host Evolution of Norovirus GII.4 in a Chronic Infected Patient With Hematopoietic Stem Cell Transplantation. Front Microbiol. 2020 Mar 9;11:375.
6.Yang X, Wang Q, Sun Y, Zhang Z, Wuchty S, Liang Z*, Dong Y. Genomic differences of patients with hematologic malignancies in different age groups. Commun Biol. 2024 Dec 6;7(1):1630.
7.Xie W, Lai Z, Wang Q, Wang W, Wang J, Liu H, Liang Z*, Dong Y. Metabolomics and machine learning approaches for diagnostic biomarkers screening in systemic light chain amyloidosis. Ann Hematol. 2025 Mar;104(3):1669-1678.
8.Yang X, Shen Y, Tang B, Zhu J, Wang B, Wang Q, Tian W, Wuchty S, Zhang Z, Liang Z*, Dong Y. Multi-Omics Blood Atlas Reveals Host Immune Response Features of Immunocompromised Populations Following SARS-CoV-2 Infection. Mol Cell Proteomics. 2025 Oct;24(10):101068.
9.Yang X, Zhu J, Wang Q, Tang B, Shen Y, Wang B, Ji L, Liu H, Wuchty S, Zhang Z, Dong Y, Liang Z*. Comparative analysis of dynamic transcriptomes reveals specific COVID-19 features and pathogenesis of immunocompromised populations. mSystems. 2024 Jun 18;9(6):e0138523.
10.Xiao-Ping C, Hao Z, Ru-Li F, Jin-Xing L, Yu-Jun D, Ze-Yin L*. Recombinant mannan-binding lectin magnetic beads increase pathogen detection in immunocompromised patients. Appl Microbiol Biotechnol. 2024 Feb 3;108(1):193. 7
11.Yuan J, Liang ZY*, Dong YJ, Ren HY. Autoimmune Hemolytic Anemia After Cord Blood Transplantation: A Retrospective Single-Center Experience. J Inflamm Res. 2023 Jan 4;16:1-6.
12.Song ZY, Ren HY, Dong YJ, Li Y, Yin Y, Sun YH, Wang Q, Xu WL, Liu W, Ou JP, Liang ZY*. Impact of Low-Dose rATG Prior to Matched Sibling Donor Hematopoietic Stem Cell Transplantation for Hematologic Malignancies: Reduced Risk of Chronic Graft-versus-Host Disease and Improved Survival Outcomes. Cancer Manag Res. 2020 Nov 30;12:12287-12300.
北京市西城区西什库大街8号
100034
83572211